Unknown

Dataset Information

0

Chronically reduced IL-10 plasma levels are associated with hippocampal sclerosis in temporal lobe epilepsy patients.


ABSTRACT:

Background

Increasing evidence supports the role of soluble inflammatory mediators in the pathogenesis of refractory temporal lobe epilepsy (TLE). Hippocampal sclerosis (HS) is a well-described pathohistological abnormality in TLE. The association of proinflammatory cytokines with epileptic disease profiles is well established; however, the potential significance of circulating interleukin 10 (IL-10), particularly in TLE-associated HS, is still poorly understood. Therefore, taking into consideration the neuroprotective and anticonvulsive effects of IL-10, we performed this study to examine the role of the plasma levels of IL-10 in patients with TLE with HS (TLE?+?HS), TLE without HS (TLE-HS) and with other types of epilepsy.

Methods

This study included 270 patients with refractory epilepsy who were classified into four groups: i) 34 patients with TLE?+?HS, ii) 105 patients with TLE-HS, iii) 95 patients with extra-TLE (XLE) and iv) 36 patients with idiopathic generalized epilepsy (IGE). The plasma IL-10 levels were quantified using a commercially available enzyme-linked immunosorbent assay (ELISA).

Results

IL-10 levels were significantly lower in TLE?+?HS than in TLE-HS (p?=?0.013). In a subgroup of TLE-HS patients who had seizures 1 month before sampling, patients with seizures had significantly higher IL-10 levels than patients who were seizure-free (p?=?0.039). Among a small group (n?=?15) of non-refractory TLE-HS patients, IL-10 levels showed a moderate negative correlation with the duration of epilepsy (r?=?-?0.585, p?=?0.023).

Conclusions

This study demonstrated that chronically reduced levels of plasma IL-10 were associated with HS in TLE patients, suggesting that there was an inadequate systemic anti-inflammatory immune response. These results could provide new biological insights into the pathophysiology of HS in TLE. We also found that the production of IL-10 could be affected by the seizure frequency and declined concomitantly with increased disease durations. Therefore, the measurement of plasma IL-10 may have diagnostic value as a biomarker for stratifying TLE?+?HS from other epilepsy types or as a marker of disease progression towards a progressive form of epilepsy.

SUBMITTER: Basnyat P 

PROVIDER: S-EPMC7291453 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Chronically reduced IL-10 plasma levels are associated with hippocampal sclerosis in temporal lobe epilepsy patients.

Basnyat Pabitra P   Pesu Marko M   Söderqvist Mikael M   Grönholm Anna A   Liimatainen Suvi S   Peltola Maria M   Raitanen Jani J   Peltola Jukka J  

BMC neurology 20200612 1


<h4>Background</h4>Increasing evidence supports the role of soluble inflammatory mediators in the pathogenesis of refractory temporal lobe epilepsy (TLE). Hippocampal sclerosis (HS) is a well-described pathohistological abnormality in TLE. The association of proinflammatory cytokines with epileptic disease profiles is well established; however, the potential significance of circulating interleukin 10 (IL-10), particularly in TLE-associated HS, is still poorly understood. Therefore, taking into c  ...[more]

Similar Datasets

| S-EPMC6491759 | biostudies-literature
| S-EPMC5354818 | biostudies-literature
| S-EPMC3176424 | biostudies-literature
| S-EPMC9159256 | biostudies-literature
| S-EPMC3352899 | biostudies-literature
| S-EPMC1572589 | biostudies-other
| S-EPMC5856714 | biostudies-literature
| S-EPMC5650939 | biostudies-literature
| S-EPMC8429827 | biostudies-literature
| S-EPMC9177400 | biostudies-literature